Sacramento Takes Formal Step Toward Pursuing MLB Expansion Franchise Matthieu Pigasse The Socialist Banker Venezuela Tapped to Restructure Finances and Lure Investors Micron Technology Stock Surges on UBS Bullish Outlook and Strong Memory Chip Demand Dow Jones Futures Steady as Trump Hints at Iran Deal Tesla and AI Stocks Approach Potential Buy Points Singapore Regulator Urges Banks to Accelerate Account Openings for Wealthy Clients Prairie Operating PROP Faces NearTerm Headwinds But Bullish Thesis Remains Intact Opendoor Technologies OPEN Q1 2026 Earnings NarrowerThanExpected Loss Signals Operational Improvement Bioventus BVS Q1 2026 Earnings EPS Surges Past Expectations Despite Revenue Opacity Kiora Pharmaceuticals Q1 2026 Earnings EPS Beat Masks Continued PreRevenue Status as Stock Slips CTS Q1 2026 Earnings EPS Surges Past Estimates Driving Shares Higher AGPU Q1 2025 Earnings Massive EPS Miss Sends Shares Lower Cohen Steers Inc CNS Q1 2026 Earnings EPS Falls Short of Estimates Stock Declines Modestly Abbott Laboratories ABT Edges Lower Amid Market Consolidation Key Levels in Focus Orchestra BioMed OBIO Edges Higher Navigating Key Support and Resistance Levels Regency Centers REG Holds Steady Near Support as Retail Real Estate Shows Resilience Iron Horse Acquisitions II Corp IRHOU Holds Steady at 1017 Amid Quiet Trading GrowGeneration Corp GRWG Holds Steady Near Support as Cannabis Sector Watches for Breakout LGND Q1 2026 Earnings Earnings Miss Weighed Against Upbeat Strategic Progress HHS Q2 2025 Earnings Narrowing PerShare Loss Amid Restructuring Efforts SOJE Q1 2026 Earnings Earnings Beat Estimates Amid Steady Utility Performance ALRM Q1 2026 Earnings EPS Beats Estimates by 54 Stock Edges Higher NVVE Q2 2025 Earnings Wide Loss Reported Amidst Operational Challenges Stock Gains 69 INBS Q1 2025 Earnings WiderthanExpected Loss Drags Shares Lower Meta Settles Landmark Social Media Addiction Lawsuit with US School District Sets Precedent for Hundreds of Similar Cases Intercorp Financial Services Q1 2026 Earnings EPS Surpasses Estimates by Nearly 11 Autolus Therapeutics AUTL Edges Higher Testing Resistance Near 181